Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Ann Surg. 2019 Jan;269(1):95–101. doi: 10.1097/SLA.0000000000002525

Table 2.

Hazard Ratios for the Risk of Cancer from Cox Regression Modelsa

Outcomeb N Unadjusted HR 95% CI P-value Adjusted HRc 95% CI P-value
All Patients Any Cancer 87996 0.70 0.63–0.77 <.001 0.67 0.60–0.74 <.001
Obesity-Associated Cancer 87996 0.60 0.52–0.70 <.001 0.59 0.51–0.69 <.001
Cancer not Associated with Obesity 87996 0.83 0.71–0.96 0.01 0.77 0.66–0.89 0.001
Women Any Cancer 71341 0.66 0.50–0.75 <.001 0.64 0.57–0.72 <.001
Obesity-Associated Cancer 71341 0.58 0.50–0.68 <.001 0.58 0.49–0.67 <.001
Cancer not Associated with Obesity 71341 0.80 0.67–0.96 0.02 0.74 0.62–0.89 0.001
Men Any Cancer 16655 0.85 0.68–1.07 0.17 0.79 0.63–1.002 0.054
Obesity-Associated Cancer 16655 0.71 0.47–1.07 0.1 0.7 0.46–1.07 0.1
Cancer not Associated with Obesity 16655 0.94 0.71–1.24 0.64 0.85 0.64–1.12 0.25
a

All models accounted for matching on age, sex, BMI, Elixhauser comorbidity index score and study site

b

all outcomes start at 6 months after the index date

c

Models adjusted for race, diabetes, hyperlipidemia, hypertension, coronary artery disease, peripheral vascular disease, nonalcoholic steatohepatitis, a history of smoking, alcohol use, and use of hormone replacement therapy.